GlassScriptPhysician profile
Taylor F Daniel
NPI 1851861900
$531.10
in general payments reported to CMS, 2019-2025
10 companies · $75.91 in 2025
The $75.91 reported for 2025 was less than what a typical Pediatrics (Nurse Practitioner) provider received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $62.46 · 2022: $48.69 · 2023: $129 · 2024: $215 · 2025: $75.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $364 · Education: $56.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $363.94 |
| Education | $56.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $161.24 | 2023-2025 | Dupixent |
| Novo Nordisk INC | $131.36 | 2024-2025 | Wegovy |
| Merck Sharp & Dohme LLC | $61.80 | 2021-2023 | Gardasil 9, Vaxelis, Vaxneuvance |
| Corium, LLC | $36.12 | 2021-2022 | |
| Alk-Abello, INC | $34.06 | 2023-2024 | Odactra, Grastek, Ragwitek |
| Sanofi Pasteur INC. | $28.69 | 2023 | |
| Pfizer INC. | $25.70 | 2023 | |
| Sobi, INC | $20.49 | 2023 | Synagis |
| Takeda Pharmaceuticals U.S.A., INC. | $16.56 | 2021 | |
| Cranial Technologies, INC | $15.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Taylor Daniel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.